☰

Ryan P. Abo, Ph.D. - Publications

Affiliations: 
2010 Biomedical Informatics University of Utah, Salt Lake City, UT 
Area:
Genetics, Epidemiology, Statistics
Tree Info Similar researchers PubMed Report error

40/60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Vasbinder MM, Gozgit JM, Abo RP, Kunii K, Kuplast-Barr KG, Gui B, Lu AZ, Swinger KK, Wigle TJ, Blackwell DJ, Majer CR, Ren Y, Niepel M, Varsamis ZA, Nayak SP, et al. Abstract DDT02-01: RBN-2397: A first-in-class PARP7 inhibitor targeting a newly discovered cancer vulnerability in stress-signaling pathways Cancer Research. 80. DOI: 10.1158/1538-7445.Am2020-Ddt02-01  0.329
2016 Niu N, Liu T, Cairns J, Ly RC, Tan X, Deng M, Fridley BL, Kalari KR, Abo RP, Jenkins G, Batzler A, Carlson EE, Barman P, Moran S, Heyn H, et al. Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines. Human Molecular Genetics. 25: 4819-4834. PMID 28173075 DOI: 10.1093/Hmg/Ddw301  0.364
2016 Niu N, Liu T, Cairns J, Ly RC, Tan X, Deng M, Fridley BL, Kalari KR, Abo RP, Jenkins G, Batzler A, Carlson EE, Barman P, Moran S, Heyn H, et al. Metformin Pharmacogenomics: A genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines. Human Molecular Genetics. PMID 27616566 DOI: 10.1093/hmg/ddw301  0.366
2016 Camp NJ, Lin WY, Bigelow A, Burghel GJ, Mosbruger T, Parry M, Waller RG, Rigas SH, Tai PY, Berrett K, Rajamanickam V, Cosby R, Brock IW, Jones B, Connley D, ... ... Abo R, et al. Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Research. PMID 26795348 DOI: 10.1158/0008-5472.Can-15-1629  0.63
2016 Chapuy B, Cheng H, Watahiki A, Ducar MD, Tan Y, Chen L, Roemer MG, Ouyang J, Christie AL, Zhang L, Gusenleitner D, Abo RP, Farinha P, von Bonin F, Thorner AR, et al. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biologic heterogeneity of the disease. Blood. PMID 26773040 DOI: 10.1182/Blood-2015-09-672352  0.317
2015 Chapuy B, Roemer MG, Stewart C, Tan Y, Abo RP, Zhang L, Dunford AJ, Meredith DM, Thorner AR, Jordanova ES, Liu G, Feuerhake F, Ducar MD, Illerhaus G, Gusenleitner D, et al. Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood. PMID 26702065 DOI: 10.1182/Blood-2015-10-673236  0.338
2015 Abo RP, Ducar M, Garcia EP, Thorner AR, Rojas-Rudilla V, Lin L, Sholl LM, Hahn WC, Meyerson M, Lindeman NI, Van Hummelen P, MacConaill LE. BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers. Nucleic Acids Research. 43: e19. PMID 25428359 DOI: 10.1093/Nar/Gku1211  0.344
2015 Abo RP, Lin L, Hunter SS, Dolcen DN, Paquette RR, Laing A, Waal Ld, Thorner AR, Ducar MD, Ziaugra L, Hahn WC, Meyerson ML, MacConaill LE, Hummelen PV. Abstract 4867: Comparative analysis of RNA sequencing methods for characterization of cancer transcriptomics Cancer Research. 75: 4867-4867. DOI: 10.1158/1538-7445.Am2015-4867  0.348
2015 Garcia EP, Ligon AH, Abo RP, Cin PSD, Weremowicz S, Shivdasani P, Davineni PK, Zepf DL, Ducar MD, Hummelen PV, Jia Y, Kuo FC, Sholl LM, MacConaill LE, Lindeman NI. Abstract 2991: Detection of gene rearrangements using OncoPanel: a targeted next-generation sequencing assay Cancer Research. 75: 2991-2991. DOI: 10.1158/1538-7445.Am2015-2991  0.42
2015 Lin L, Abo R, Dolcen D, Paquette R, Laing A, Waal Ld, Thorner A, Ducar M, Ziaugra L, Wollison B, Breneiser M, Hahn W, Meyerson M, Hummelen PV, MacConaill L. Abstract 1115: Targeted RNA sequencing improves transcript analysis in cancer samples Cancer Research. 75: 1115-1115. DOI: 10.1158/1538-7445.Am2015-1115  0.332
2014 Li L, Fridley BL, Kalari K, Niu N, Jenkins G, Batzler A, Abo RP, Schaid D, Wang L. Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines Bmc Genomics. 15. PMID 24483146 DOI: 10.1186/1471-2164-15-93  0.401
2014 Fridley BL, Abo R, Tan XL, Jenkins GD, Batzler A, Moyer AM, Biernacka JM, Wang L. Integrative gene set analysis: Application to platinum pharmacogenomics Omics a Journal of Integrative Biology. 18: 34-41. PMID 24199607 DOI: 10.1089/Omi.2013.0099  0.334
2014 Abo RP, Garcia EP, Ducar M, Adusumilli R, Breneiser M, Rojas-Rudilla V, Sholl LM, Lindeman NI, Meyerson ML, Hahn WC, Hummelen PV, MacConaill LE. Abstract 5321: BreaKmer: Detection of structural rearrangements in targeted next-generation sequencing data using kmers Cancer Research. 74: 5321-5321. DOI: 10.1158/1538-7445.Am2014-5321  0.389
2013 Jiang J, Fridley BL, Feng Q, Abo RP, Brisbin A, Batzler A, Jenkins G, Long PA, Wang L. Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system. Frontiers in Genetics. 4: 166. PMID 24009623 DOI: 10.3389/Fgene.2013.00166  0.444
2013 Ellsworth KA, Eckloff BW, Li L, Moon I, Fridley BL, Jenkins GD, Carlson E, Brisbin A, Abo R, Bamlet W, Petersen G, Wieben ED, Wang L. Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. Plos One. 8: e70216. PMID 23936393 DOI: 10.1371/Journal.Pone.0070216  0.311
2013 Ellsworth KA, Moon I, Eckloff BW, Fridley BL, Jenkins GD, Batzler A, Biernacka JM, Abo R, Brisbin A, Ji Y, Hebbring S, Wieben ED, Mrazek DA, Weinshilboum RM, Wang L. FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder. Pharmacogenetics and Genomics. 23: 156-66. PMID 23324805 DOI: 10.1097/Fpc.0B013E32835Dc133  0.448
2013 Niu N, Tan X, Fridley BL, Schaid DJ, Abo RP, Batzler A, Carlson EE, Jenkins G, Moran S, Heyn HA, Badosa ME, Wang L. Abstract 2271: Metformin pharmacogenomics: A genome-wide associate study to identify genetic and epigenetic biomarkers involved in metformin response. Cancer Research. 73: 2271-2271. DOI: 10.1158/1538-7445.Am2013-2271  0.4
2013 Ellsworth KA, Eckloff BW, Li L, Moon I, Fridley BL, Jenkins GD, Carlson E, Brisbin A, Abo R, Bamlet W, Petersen G, Wieben ED, Wang L. Abstract 2209: Contribution ofFKBP5genetic variation to gemcitabine treatment and survival in pancreatic cancer. Cancer Research. 73: 2209-2209. DOI: 10.1158/1538-7445.Am2013-2209  0.445
2012 Niu N, Schaid DJ, Abo RP, Kalari K, Fridley BL, Feng Q, Jenkins G, Batzler A, Brisbin AG, Cunningham JM, Li L, Sun Z, Yang P, Wang L. Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study. Bmc Cancer. 12: 422. PMID 23006423 DOI: 10.1186/1471-2407-12-422  0.445
2012 Knight S, Abo RP, Abel HJ, Neklason DW, Tuohy TM, Burt RW, Thomas A, Camp NJ. Shared genomic segment analysis: the power to find rare disease variants. Annals of Human Genetics. 76: 500-9. PMID 22989048 DOI: 10.1111/J.1469-1809.2012.00728.X  0.58
2012 Abo R, Jenkins GD, Wang L, Fridley BL. Identifying the genetic variation of gene expression using gene sets: application of novel gene Set eQTL approach to PharmGKB and KEGG. Plos One. 7: e43301. PMID 22905253 DOI: 10.1371/Journal.Pone.0043301  0.441
2012 Ji Y, Nordgren KK, Chai Y, Hebbring SJ, Jenkins GD, Abo RP, Peng Y, Pelleymounter LL, Moon I, Eckloff BW, Chai X, Zhang J, Fridley BL, Yee VC, Wieben ED, et al. Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 1984-92. PMID 22807109 DOI: 10.1124/Dmd.112.046953  0.415
2012 Chalise P, Batzler A, Abo R, Wang L, Fridley BL. Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis. Omics : a Journal of Integrative Biology. 16: 363-73. PMID 22734853 DOI: 10.1089/Omi.2011.0126  0.385
2012 Abo R, Hebbring S, Ji Y, Zhu H, Zeng ZB, Batzler A, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Fridley B, Schaid D, Kamatani N, Nakamura Y, et al. Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics. Pharmacogenetics and Genomics. 22: 247-53. PMID 22322242 DOI: 10.1097/Fpc.0B013E32835001C9  0.462
2012 Hebbring SJ, Chai Y, Ji Y, Abo RP, Jenkins GD, Fridley B, Zhang J, Eckloff BW, Wieben ED, Weinshilboum RM. Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization. Journal of Neurochemistry. 120: 881-90. PMID 22220685 DOI: 10.1111/J.1471-4159.2012.07646.X  0.459
2012 Li L, Schaid DJ, Fridley BL, Kalari KR, Jenkins GD, Abo RP, Batzler A, Moon I, Pelleymounter L, Eckloff BW, Wieben ED, Sun Z, Yang P, Wang L. Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer. Pharmacogenetics and Genomics. 22: 105-16. PMID 22173087 DOI: 10.1097/Fpc.0B013E32834Dd7E2  0.401
2012 Camp NJ, Parry M, Knight S, Abo R, Elliott G, Rigas SH, Balasubramanian SP, Reed MW, McBurney H, Latif A, Newman WG, Cannon-Albright LA, Evans DG, Cox A. Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 176-81. PMID 22056502 DOI: 10.1158/1055-9965.Epi-11-0845  0.614
2011 Pelleymounter LL, Moon I, Johnson JA, Laederach A, Halvorsen M, Eckloff B, Abo R, Rossetti S. A novel application of pattern recognition for accurate SNP and indel discovery from high-throughput data: targeted resequencing of the glucocorticoid receptor co-chaperone FKBP5 in a Caucasian population. Molecular Genetics and Metabolism. 104: 457-69. PMID 21917492 DOI: 10.1016/J.Ymgme.2011.08.019  0.458
2011 Nordgren KK, Peng Y, Pelleymounter LL, Moon I, Abo R, Feng Q, Eckloff B, Yee VC, Wieben E, Weinshilboum RM. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 2135-47. PMID 21813468 DOI: 10.1124/Dmd.111.040857  0.45
2011 Tan XL, Moyer AM, Fridley BL, Schaid DJ, Niu N, Batzler AJ, Jenkins GD, Abo RP, Li L, Cunningham JM, Sun Z, Yang P, Wang L. Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5801-11. PMID 21775533 DOI: 10.1158/1078-0432.Ccr-11-1133  0.44
2011 Feng Q, Kalari K, Fridley BL, Jenkins G, Ji Y, Abo R, Hebbring S, Zhang J, Nye MD, Leeder JS, Weinshilboum RM. Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlation. Molecular Genetics and Metabolism. 102: 126-33. PMID 21093336 DOI: 10.1016/J.Ymgme.2010.10.010  0.401
2011 Abo R, Knight S, Thomas A, Camp NJ. Automated construction and testing of multi-locus gene-gene associations. Bioinformatics (Oxford, England). 27: 134-6. PMID 21076150 DOI: 10.1093/Bioinformatics/Btq616  0.605
2010 Abo R, Wong J, Thomas A, Camp NJ. Haplotype association analyses in resources of mixed structure using Monte Carlo testing. Bmc Bioinformatics. 11: 592. PMID 21143908 DOI: 10.1186/1471-2105-11-592  0.614
2010 Curtin K, Wolff RK, Herrick JS, Abo R, Slattery ML. Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor Bmc Medical Genetics. 11: 170-170. PMID 21129206 DOI: 10.1186/1471-2350-11-170  0.529
2010 Abo RP, Parry M, Rigas SH, Cox A, Camp NJ. Abstract 2844: Association of genetic variants in TNFRSF10B and breast cancer Cancer Research. 70: 2844-2844. DOI: 10.1158/1538-7445.Am10-2844  0.659
2010 Parry M, Elliott G, Abo R, Camp NJ, Neal DE, Donovan JL, Hamdy FC, Cox A. Abstract 2843: Caspase-8 gene SNPs in prostate cancer susceptibility: a replication study Cancer Research. 70: 2843-2843. DOI: 10.1158/1538-7445.Am10-2843  0.605
2009 Piccolo SR, Abo RP, Allen-Brady K, Camp NJ, Knight S, Anderson JL, Horne BD. Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study. Bmc Proceedings. 3: S46. PMID 20018038 DOI: 10.1186/1753-6561-3-S7-S46  0.665
2009 Knight S, Abo RP, Wong J, Thomas A, Camp NJ. Pedigree association: assigning individual weights to pedigree members for genetic association analysis. Bmc Proceedings. 3: S121. PMID 20017987 DOI: 10.1186/1753-6561-3-S7-S121  0.552
2009 Shephard ND, Abo R, Rigas SH, Frank B, Lin WY, Brock IW, Shippen A, Balasubramanian SP, Reed MW, Bartram CR, Meindl A, Schmutzler RK, Engel C, Burwinkel B, Cannon-Albright LA, et al. A breast cancer risk haplotype in the caspase-8 gene. Cancer Research. 69: 2724-8. PMID 19318553 DOI: 10.1158/0008-5472.Can-08-4266  0.701
2008 Abo R, Knight S, Wong J, Cox A, Camp NJ. hapConstructor: automatic construction and testing of haplotypes in a Monte Carlo framework. Bioinformatics (Oxford, England). 24: 2105-7. PMID 18653522 DOI: 10.1093/Bioinformatics/Btn359  0.622
Low-probability matches (unlikely to be authored by this person)
2015 Chapuy B, Cheng H, Watahiki A, Ducar MD, Gusenleitner D, Chen L, Roemer MG, Quyang J, Christie AL, Zhang L, Tan Y, Abo RP, Bonin F, Thorner AR, Sun HH, et al. Diffuse Large B-Cell Lymphoma Patient-Derived Xenograft Models Capture Molecular and Biologic Heterogeneity and Inform Therapy Blood. 126: 817-817. DOI: 10.1182/Blood.V126.23.817.817  0.296
2020 Gozgit JM, Vasbinder MM, Abo RP, Kunii K, Kuplast-Barr KG, Gui B, Lu AZ, Swinger KK, Wigle TJ, Blackwell DJ, Majer CR, Ren Y, Niepel M, Varsamis ZA, Nayak SP, et al. Abstract 3405: PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition leads to tumor regression Cancer Research. 80: 3405-3405. DOI: 10.1158/1538-7445.Am2020-3405  0.292
2015 Fendler B, Abo R, Hunter S, Ducar M, Garcia E, Hummelen PV, Lindeman N, MacConaill L. Abstract 4850: Identifying copy number alterations from targeted sequencing data Cancer Research. 75: 4850-4850. DOI: 10.1158/1538-7445.Am2015-4850  0.285
2020 Schenkel L, Molina J, Swinger K, Abo R, Blackwell D, Cheung A, Church W, Kuplast-Barr K, Lu A, Minissale E, Niepel M, Vasbinder M, Wigle T, Richon V, Keilhack H, et al. Abstract 1038: A potent and selective PARP14 inhibitor decreases pro-tumor macrophage function and elicits inflammatory responses in tumor explants Cancer Research. 80: 1038-1038. DOI: 10.1158/1538-7445.Am2020-1038  0.281
2016 Sholl LM, Do K, Shivdasani P, Cerami E, Dubuc AM, Kuo FC, Garcia EP, Jia Y, Davineni P, Abo RP, Pugh TJ, van Hummelen P, Thorner AR, Ducar M, Berger AH, et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. Jci Insight. 1: e87062. PMID 27882345 DOI: 10.1172/Jci.Insight.87062  0.273
2019 Lu AZ, Abo R, Ren Y, Gui B, Mo JR, Blackwell D, Wigle T, Keilhack H, Niepel M. Enabling Drug Discovery for the PARP Protein Family through the Detection of Mono-ADP-Ribosylation. Biochemical Pharmacology. PMID 31075269 DOI: 10.1016/J.Bcp.2019.05.007  0.264
2017 Abo RP, Chen Z, Bailey S, Wang H, Gujja S, Yang P, Lund J, Gulcher J, Chittenden T. Abstract 3586: Comprehensive assessment of mouse contamination removal strategies from patient-derived xenograft model sequencing data Cancer Research. 77: 3586-3586. DOI: 10.1158/1538-7445.Am2017-3586  0.248
2015 Kluk MJ, Abo RP, Brown RD, Kuo FC, Dal Cin P, Pozdnyakova O, Morgan EA, Lindeman NI, DeAngelo DJ, Aster JC. Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay. Cold Spring Harbor Molecular Case Studies. 1: a000307. PMID 27148563 DOI: 10.1101/mcs.a000307  0.212
2017 Yang P, Abo R, Liu C, Chen Z, Wu H, Cui J, Yandava C, Bailey ST, Balch C, Gulcher JR, Chittenden TW. Abstract 4539: Novel feature selection strategies for enhanced predictive modeling and deep learning in the biosciences Cancer Research. 77: 4539-4539. DOI: 10.1158/1538-7445.Am2017-4539  0.2
2016 Chen Z, Abo RP, Bailey ST, Cui J, Balch C, Gulcher JR, Chittenden TW. RNA Sequencing and Genetic Disease Current Genetic Medicine Reports. 4: 49-56. DOI: 10.1007/S40142-016-0098-X  0.192
2013 Lu K, Cable PH, Abo RP, Ru H, Graffam ME, Schlieper KA, Parry NM, Levine S, Bodnar WM, Wishnok JS, Styblo M, Swenberg JA, Fox JG, Tannenbaum SR. Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation. Chemical Research in Toxicology. 26: 1893-903. PMID 24134150 DOI: 10.1021/Tx4002868  0.175
2021 Schenkel LB, Molina JR, Swinger KK, Abo R, Blackwell DJ, Lu AZ, Cheung AE, Church WD, Kunii K, Kuplast-Barr KG, Majer CR, Minissale E, Mo JR, Niepel M, Reik C, et al. A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants. Cell Chemical Biology. PMID 33705687 DOI: 10.1016/j.chembiol.2021.02.010  0.159
2021 Gozgit JM, Vasbinder MM, Abo RP, Kunii K, Kuplast-Barr KG, Gui B, Lu AZ, Molina JR, Minissale E, Swinger KK, Wigle TJ, Blackwell DJ, Majer CR, Ren Y, Niepel M, et al. PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity. Cancer Cell. PMID 34375612 DOI: 10.1016/j.ccell.2021.06.018  0.146
2014 Nagel ZD, Margulies CM, Chaim IA, McRee SK, Mazzucato P, Ahmad A, Abo RP, Butty VL, Forget AL, Samson LD. Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis. Proceedings of the National Academy of Sciences of the United States of America. 111: E1823-32. PMID 24757057 DOI: 10.1073/Pnas.1401182111  0.13
2014 De Nisco NJ, Abo RP, Wu CM, Penterman J, Walker GC. Global analysis of cell cycle gene expression of the legume symbiont Sinorhizobium meliloti. Proceedings of the National Academy of Sciences of the United States of America. 111: 3217-24. PMID 24501121 DOI: 10.1073/Pnas.1400421111  0.123
2021 Wigle T, Ren Y, Molina JR, Blackwell DJ, Schenkel LB, Swinger KK, Kuplast-Barr K, Majer CR, Church WD, Lu AZ, Mo J, Abo R, Cheung A, Dorsey BW, Niepel M, et al. Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule. Chembiochem : a European Journal of Chemical Biology. PMID 33838082 DOI: 10.1002/cbic.202100047  0.109
2013 Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey L, Haas S, Abo R, Tabebordbar M, Lee RT, Burge CB, Boyer LA. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell. 152: 570-83. PMID 23352431 DOI: 10.1016/J.Cell.2013.01.003  0.104
2014 Lu K, Abo RP, Schlieper KA, Graffam ME, Levine S, Wishnok JS, Swenberg JA, Tannenbaum SR, Fox JG. Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environmental Health Perspectives. 122: 284-91. PMID 24413286 DOI: 10.1289/Ehp.1307429  0.103
2014 Penterman J, Abo RP, De Nisco NJ, Arnold MF, Longhi R, Zanda M, Walker GC. Host plant peptides elicit a transcriptional response to control the Sinorhizobium meliloti cell cycle during symbiosis. Proceedings of the National Academy of Sciences of the United States of America. 111: 3561-6. PMID 24501120 DOI: 10.1073/Pnas.1400450111  0.098
2014 Pang YL, Abo R, Levine SS, Dedon PC. Diverse cell stresses induce unique patterns of tRNA up- and down-regulation: tRNA-seq for quantifying changes in tRNA copy number. Nucleic Acids Research. 42: e170. PMID 25348403 DOI: 10.1093/nar/gku945  0.088
Hide low-probability matches.